Skip to main content

Novo Nordisk news in 2026: 25 dated events

The latest Novo Nordisk event on this page is dated Oct 28, 2026. qz.com reported: New weight-loss drugs: what 6 drugmakers are testing.

PublicPharmaceutical Manufacturing10,000+ employeesnovonordisk.comLinkedIn

Get Novo Nordisk's live signals in Claude or ChatGPT, or by API

AskWhat changed at Novo Nordisk this week? Use Autobound signals for novonordisk.com.
Dated events
25
Last 90 days
25
Latest
Oct 28, 2026

Source: Autobound Signal API · 93 signals tracked for Novo Nordisk · updated

News · latest 10

Latest Novo Nordisk news

  1. In development
    New weight-loss drugs: what 6 drugmakers are testingNovo Nordisk is developing CagriSema and amycretin as new weight-loss drugs.
  2. Security incident
    Novo Nordisk Faces a Three-Part Test: Doctor Data Questions, a Pediatric Insulin Approval and a BuybNovo Nordisk suffered a cyberattack that exposed an internal directory classifying healthcare professionals by prescription likelihood and familiarity with its drugs.
  3. Partnership
    Podiatrist let unlicensed salesman perform surgery, then billed Medicare; Novo Nordisk partners with OpenAI to accelerate drug development; a better predictor of hypertension...Novo Nordisk has partnered with OpenAI to deploy artificial intelligence across its research, manufacturing, supply chain, and commercial operations.
  4. Partnership
  5. In development
    Novo provides update on the denecimig Biologics License Application (BLA) in the USNovo Nordisk is developing denecimig, a treatment for haemophilia A, and aims to launch it in the US in the first half of 2027, pending regulatory approval.
  6. In development
    Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fatNovo Nordisk is evaluating the effect of its once-weekly injectable semaglutide 2.4 mg in people with MASH and moderate to advanced liver fibrosis in its ongoing phase 3 ESSENCE trial, with results from the second part expected in 2029.
  7. Award
  8. Launch
    Semaglutide 2 mg Escalation Tied to Lower MACE vs Tirzepatide Switch in T2DNovo Nordisk released a retrospective US claims analysis showing that adults with type 2 diabetes who escalated semaglutide from 1 mg to 2 mg had a 6% lower adjusted MACE risk than those who switched to tirzepatide.
  9. Acquisition
  10. Partnership
    Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596Novo Nordisk has entered into an exclusive license agreement with Hengrui Pharma for HRS-1596, a phase 1-ready GLP-1/GIP dual receptor agonist, in a deal potentially worth up to $2.6 billion.

Showing 10 of 25 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novo Nordisk with the Signal API

One POST /v1/companies/enrich call with novonordisk.com returns Novo Nordisk news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novonordisk.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Novo Nordisk news

What is the latest news on Novo Nordisk?
The newest event on this page is dated Oct 28, 2026. qz.com reported: New weight-loss drugs: what 6 drugmakers are testing. This page lists 25 dated events for Novo Nordisk, each with a source link.
What is going on with Novo Nordisk?
The 10 latest events on this page cover in development (3), security incident (1), partnership (3), award (1), launch (1) and acquisition (1). The newest: Oct 28, 2026: New weight-loss drugs: what 6 drugmakers are testing (qz.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →